Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ute Hegenbart

Showing results (51-60 of 237) with videos related to

Pageof 24
Sort By:
Cancer Medicine|April 26, 2016
Flow cytometry-based characterization of underlying clonal B and plasma cells in patients with light chain amyloidosisKatharina Lisenko, Stefan O Schönland, Anna Jauch, et al.
Haematologica|January 12, 2019
Allogeneic transplantation in high-risk chronic lymphocytic leukemia: a single-center, intent-to-treat analysisAlmuth Hoffmann, Sascha Dietrich, Susanne Hain, et al.
Virchows Archiv : an International Journal of Pathology|April 9, 2010
Amyloid in endomyocardial biopsiesBarbara Kieninger, Magdalena Eriksson, Reinhard Kandolf, et al.
Blood|May 28, 2017
AL amyloidosis patients with low amyloidogenic free light chain levels at first diagnosis have an excellent prognosisTobias Dittrich, Tilmann Bochtler, Christoph Kimmich, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|October 22, 2014
Improvement of risk assessment in systemic light-chain amyloidosis using human placental growth factorArnt V Kristen, Johannes Rinn, Ute Hegenbart, et al.
Nature Communications|March 22, 2019
Cryo-EM structure of a light chain-derived amyloid fibril from a patient with systemic AL amyloidosisLynn Radamaker, Yin-Hsi Lin, Karthikeyan Annamalai, et al.
Bone Marrow Transplantation|February 13, 2025
Intermediate-dose TBI/fludarabine conditioning for allogeneic hematopoietic cell transplantation in patients with peripheral T-cell lymphomaIsabelle Krämer, Laila König, Thomas Luft, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|January 25, 2018
Obesity is a significant susceptibility factor for idiopathic AA amyloidosisNorbert Blank, Ute Hegenbart, Sascha Dietrich, et al.
Haematologica|March 26, 2017
Novel recurrent chromosomal aberrations detected in clonal plasma cells of light chain amyloidosis patients show potential adverse prognostic effect: first results from a genome-wide copy number array analysisMartin Granzow, Ute Hegenbart, Katrin Hinderhofer, et al.
The Journal of Molecular Diagnostics : JMD|March 28, 2009
Hereditary apolipoprotein AI-associated amyloidosis in surgical pathology specimens: identification of three novel mutations in the APOA1 geneMagdalena Eriksson, Stefan Schönland, Saniye Yumlu, et al.
Pageof 24

Showing results (51-60 of 237) with videos related to

Sort By:
Pageof 24
Cancer Medicine|April 26, 2016
Flow cytometry-based characterization of underlying clonal B and plasma cells in patients with light chain amyloidosisKatharina Lisenko, Stefan O Schönland, Anna Jauch, et al.
Haematologica|January 12, 2019
Allogeneic transplantation in high-risk chronic lymphocytic leukemia: a single-center, intent-to-treat analysisAlmuth Hoffmann, Sascha Dietrich, Susanne Hain, et al.
Virchows Archiv : an International Journal of Pathology|April 9, 2010
Amyloid in endomyocardial biopsiesBarbara Kieninger, Magdalena Eriksson, Reinhard Kandolf, et al.
Blood|May 28, 2017
AL amyloidosis patients with low amyloidogenic free light chain levels at first diagnosis have an excellent prognosisTobias Dittrich, Tilmann Bochtler, Christoph Kimmich, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|October 22, 2014
Improvement of risk assessment in systemic light-chain amyloidosis using human placental growth factorArnt V Kristen, Johannes Rinn, Ute Hegenbart, et al.
Nature Communications|March 22, 2019
Cryo-EM structure of a light chain-derived amyloid fibril from a patient with systemic AL amyloidosisLynn Radamaker, Yin-Hsi Lin, Karthikeyan Annamalai, et al.
Bone Marrow Transplantation|February 13, 2025
Intermediate-dose TBI/fludarabine conditioning for allogeneic hematopoietic cell transplantation in patients with peripheral T-cell lymphomaIsabelle Krämer, Laila König, Thomas Luft, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|January 25, 2018
Obesity is a significant susceptibility factor for idiopathic AA amyloidosisNorbert Blank, Ute Hegenbart, Sascha Dietrich, et al.
Haematologica|March 26, 2017
Novel recurrent chromosomal aberrations detected in clonal plasma cells of light chain amyloidosis patients show potential adverse prognostic effect: first results from a genome-wide copy number array analysisMartin Granzow, Ute Hegenbart, Katrin Hinderhofer, et al.
The Journal of Molecular Diagnostics : JMD|March 28, 2009
Hereditary apolipoprotein AI-associated amyloidosis in surgical pathology specimens: identification of three novel mutations in the APOA1 geneMagdalena Eriksson, Stefan Schönland, Saniye Yumlu, et al.
Pageof 24